Copyright
©The Author(s) 2024.
World J Clin Oncol. Jun 24, 2024; 15(6): 695-716
Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.695
Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.695
Serial No. | Sample size | Findings | Ref. |
1 | - | IGF-MAPK cascade, p38 MAPK pathway, p53 pathway, and FAS signaling pathway as highly enriched among dysregulated miRNAs in GBC | Saxena et al[51] |
2 | - | PARP1 rs1136410 (A/G) associated with early onset of GBC | Anjali et al[52] |
3 | GBC (29), controls (29) | VEGF-A expression can be used as potential prognostic biomarker in GBC | Singh et al[53] |
4 | - | Studied the prognostic significance of the oxidative stress marker 8-OH-dG and genes associated with the BER pathway | Singh et al[54] |
5 | GBC (25) | In gallbladder cancer patients, mutations were identified in both P53 and codon 12 of KRAS | Shukla et al[55] |
6 | - | Mutations in the sorcin gene associated with poor overall survival in GBC | Shabnam et al[56] |
7 | GBC (523), controls (274) | Studied the TERT-CLPTM1L and 8q24 Genetic Variants in GBC | Yadav et al[57] |
8 | GBC (50) | Individual and repetitive mutations of shh gene in GBC can be used as diagnostic marker | Dixit et al[58] |
9 | GBC (50) | Overexpression of Her2/neu and Ki67 in gallbladder cancer associated with lymph node metastasis | Pujani et al[59] |
10 | GBC (541), controls (307) | KRAS rs61764370 polymorphism is significantly associated with GBC | Kazmi et al[60] |
11 | - | Studied Epigenetic silencing of APC in advanced GBC. | Tekcham et al[61] |
12 | GBC (24) | Found 7 hypermethylated or down-regulated (e.g., FBN1, LPP, and SOD3) and 61 hypomethylated or up-regulated markers (e.g., HBE1, SNRPF, TPD52) for GBC | Sharma et al[62] |
13 | Cases (50) | The level of EGFR expression correlates with the aggressiveness of the disease | Kumar et al[63] |
14 | GBC (52) | Tγδ17 could serve as a potential predictive biomarker in GBC | Patil et al[64] |
15 | GBC (30) | The MTHFR A1298C polymorphism associated with development of GBC | Dixit et al[65] |
16 | GBC (37) | Telomere dysfunction and alterations are the earlier events in progression of GBC | Poojary et al[66] |
17 | GBC (148), controls (256) | CYP-17 gene polymorphism is associated with risk of gallbladder cancer | Dwivedi et al[67] |
18 | - | LXR-β polymorphisms associated with GBC | Sharma et al[68] |
19 | GBC (195), controls (300) | Vascular endothelial growth factor single nucleotide polymorphism associated with GBC | Mishra et al[69] |
20 | GBC (35) | mitochondrial D-loop mutation associated with GBC | Maurya et al[70] |
21 | GBC (410), controls (210) | Estrogen and progesterone receptor sequence associated with increased risk of GBC | Srivastava et al[71] |
22 | - | KRAS p.Q25H polymorphism associated with development of GBC | Parmanik et al[72] |
23 | GBC (230), controls (230) | Caspase-8 polymorphisms associated with GBC | Srivastava et al[73] |
24 | GBC (51) | p53 mutation are early events in the evolution of GBC | Agrawal et al[74] |
25 | GBC (185), controls (195) | CYP7A1 haplotype associated with GBC | Srivastava et al[75] |
26 | GBC (230), controls (230) | The role of pre-microRNA variants in GBC uncertain | Srivastava et al[76] |
27 | GBC (62) | Most common alteration in the p53 was frameshift mutation at codon 271 | Nigam et al[77] |
28 | GBC (40) | High LOH in CDH1 associated with pathogenesis of GBC | Priya et al[78] |
29 | GBC (212), controls (219) | Studied the DNMT3B -579 G > T promoter polymorphism | Srivastava et al[79] |
30 | GBC (233), controls (260) | Angiotensin I-converting enzyme insertion/deletion polymorphism associated with GBC | Srivastava et al[80] |
31 | GBC (126), controls (190) | Role of DNA repair pathways GB carcinogenesis | Srivastava et al[81] |
32 | GBC (171), controls (221) | Patients with ABCG8 variant allele are at a higher risk of GBC | Srivastava et al[82] |
33 | GBC (185), controls (200) | Complement receptor polymorphism associated with pathogenesis of GBC | Srivastava and Mittal[83] |
34 | GBC (173), controls (204) | Single nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1; associated with low risk for GBC | Srivastava et al[84] |
35 | GBC (144), controls (210) | Role of CCR5+/Delta32 polymorphism associated with risk of GBC | Srivastava et al[85] |
36 | GBC (124), controls (166) | IL-1 gene polymorphisms associated with GBC | Vishnoi et al[86] |
37 | GBC (142), controls (217) | CYP1A1 C allele frequency associated with GBC | Pandey et al[87] |
38 | - | CYP7A1 polymorphism associated with GBC | Srivastava et al[88] |
39 | - | The X (+), D haplotype of APOB is associated risk for development of GBC | Pandey et al[89] |
40 | - | NAT2 slow acetylator phenotype associated with risk of GBC | Pandey et al[90] |
41 | GBC (129), controls (208) | LRPAP1 polymorphism associated with GBC | Pandey et al[91] |
42 | GBC (39) | Mutation in codon 12 of the K-ras oncogene associated with GBC, which indicate role of chronic inflammation in gallbladder carcinogenesis. | Singh et al[92] |
43 | GBC (117), controls (137) | The apoB-XbaI gene polymorphism associated with GBC | Singh et al[93] |
- Citation: Kumar A, Sarangi Y, Gupta A, Sharma A. Gallbladder cancer: Progress in the Indian subcontinent. World J Clin Oncol 2024; 15(6): 695-716
- URL: https://www.wjgnet.com/2218-4333/full/v15/i6/695.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i6.695